Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors

Journal of Molecular Neuroscience

Volumn 33, Issue 3, 2007, Pages 225-231

  Wang, Hank S ^a   Oh, David S ^a,b   Ohning, Gordon V ^a,b   Pisegna, Joseph R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Cancer cachexia; Endogenous; Gastrin; Ghrelin; Metastatic neuroendocrine tumors; Orexigenic; Somatostatin

Indexed keywords

GHRELIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; TUMOR LOCALIZATION;

ADULT; AGED; APPETITE; BIOLOGICAL MARKERS; BODY MASS INDEX; CACHEXIA; CHROMOGRANIN A; FEMALE; GASTRINS; GHRELIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PROSPECTIVE STUDIES;

EID: 36949030018     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-0004-9     Document Type: Article

References (34)

1. Abou-Saif, A., Gibril, F., Ojeaburu, J. V., Bashir, S., Entsuah, L. K., Asgharian, B., et al. (2003). Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas. Cancer, 98, 249-261.
2. Akamizu, T., Takaya, K., Irako, T., Hosoda, H., Teramukai, S., Matsuyama, A., et al. (2004). Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. European Journal of Endocrinology, 150, 447-455.
3. Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J. C., De Baere, T., Mitry, E., et al. (2001). Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours. European Journal of Cancer, 37, 1014-1019.
4. Bordi, C., D'Adda, T., Azzoni, C., Pilato, F. P., & Caruana, P. (1995). Hypergastrinemia and gastric enterochromaffin-like cells. American Journal of Surgical Pathology, 19, S8-S19.
5. Broglio, F., Gottero, C., Prodam, F., Gauna, C., Muccioli, G., Papotti, M., et al. (2004). Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. Journal of Clinical Endocrinology and Metabolism, 89, 3062-3065.
6. Corbetta, S., Peracchi, M., Cappiello, V., Lania, A., Lauri, E., Vago, L., et al. (2003). Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: Identification of one pancreatic ghrelinoma. Journal of Clinical Endocrinology and Metabolism, 88, 3117-3120.
7. Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., et al. (2002). Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
8. Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M. S., Suganuma, T., et al. (2000). Ghrelin, a novel growth hormonereleasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 141, 4255-4261.
9. Dornonville de la Cour, C., Bjorkqvist, M., Sandvik, A. K., Bakke, I., Zhao, C. M., Chen, D., et al. (2001). A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regulatory Peptides, 99, 141-150.
10. Ducreux, M., Ruszniewski, P., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., et al. (2000). The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. American Journal of Gastroenterology, 95, 3276-3281.
11. Freda, P. U., Reyes, C. M., Conwell, I. M., Sundeen, R. E., & Wardlaw, S. L. (2003). Serum ghrelin levels in acromegaly: Effects of surgical and long-acting octreotide therapy. Journal of Clinical Endocrinology and Metabolism, 88, 2037-2044.
12. Fykse, V., Sandvik, A. K., Qvigstad, G., Falkmer, S. E., Syversen, U., & Waldum, H. L. (2004). Treatment of ECL cell carcinoids with octreotide LAR. Scandinavian Journal of Gastroenterology, 39, 621-628.
13. Garcia, J. M., Garcia-Touza, M., Hijazi, R. A., Taffet, G., Epner, D., Mann, D., et al. (2005). Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. Journal of Clinical Endocrinology and Metabolism, 90, 2920-2926.
14. Hanada, T., Toshinai, K., Kajimura, N., Nara-Ashizawa, N., Tsukada, T., Hayashi, Y., et al. (2003). Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochemical and Biophysical Research Communications, 301, 275-279.
15. Haqq, A. M., Stadler, D. D., Rosenfeld, R. G., Pratt, K. L., Weigle, D. S., Frayo, R. S., et al. (2003). Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism, 88, 3573-3576.
16. Imtiaz, K. E., Monteith, P., & Khaleeli, A. (2000). Complete histological regression of metastatic carcinoid tumour after treatment with octreotide. Clinica Endocrinologica, 53, 755-758.
17. Inui, A., Asakawa, A., Bowers, C. Y., Mantovani, G., Laviano, A., Meguid, M. M., et al. (2004). Ghrelin, appetite, and gastric motility: The emerging role of the stomach as an endocrine organ. FASEB Journal, 18, 439-456.
18. Kojima, M. & Kangawa, K. (2005) Ghrelin: Structure and function. Physiological Reviews, 85, 495-522.
19. Neary, N. M., Small, C. J., Wren, A. M., Lee, J. L., Druce, M. R., Palmieri, C., et al. (2004). Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 89, 2832-2836.
20. Papotti, M., Cassoni, P., Volante, M., Deghenghi, R., Muccioli, G., & Ghigo, E. (2001). Ghrelin-producing endocrine tumors of the stomach and intestine. Journal of Clinical Endocrinology and Metabolism, 86, 5052-5059.
21. Popovic, V., Miljic, D., Pekic, S., Pesko, P., Djurovic, M., Doknic, M., et al. (2005). Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. Journal of Clinical Endocrinology and Metabolism, 90, 2187-2191.
22. Ramos, E. J., Suzuki, S., Marks, D., Inui, A., Asakawa, A., & Meguid, M. M. (2004). Cancer anorexia-cachexia syndrome: Cytokines and neuropeptides. Current Opinion in Clinical Nutrition and Metabolic Care, 7, 427-434.
23. Rindi, G., Savio, A., Torsello, A., Zoli, M., Locatelli, V., Cocchi, D., et al. (2002). Ghrelin expression in gut endocrine growths. Histochemistry and Cell Biology, 117, 521-525.
24. Rigamonti, A. E., Pincelli, A. I., Corra, B., Viarengo, R., Bonomo, S. M., Galimberti, D., et al. (2002). Plasma ghrelin concentrations in elderly subjects: Comparison with anorexic and obese patients. Journal of Endocrinology, 175, R1-R5.
25. Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M. S., Tanaka, M., et al. (2002). Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology and Metabolism, 87, 240-244.
26. Shimada, M., Date, Y., Mondal, M. S., Toshinai, K., Shimbara, T., Fukunaga, K., et al. (2003). Somatostatin suppresses ghrelin secretion from the rat stomach. Biochemical and Biophysical Research Communications, 302, 520-525.
27. Shimizu, Y., Nagaya, N., Isobe, T., Imazu, M., Okumura, H., Hosoda, H., et al. (2003). Increased plasma ghrelin level in lung cancer cachexia. Clinical Cancer Research, 9, 774-778.
28. Silva, A. P., Bethmann, K., Raulf, F., & Schmid, H. A. (2005). Regulation of ghrelin secretion by somatostatin analogs in rats. European Journal of Endocrinology, 152, 887-894.
29. Srivastava, A., Kamath, A., Barry, S. A., & Dayal, Y. (2004). Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells. Endocrine Pathology, 15, 47-54.
30. Thompson, G. B., van Heerden, J. A., Martin Jr., J. K., Schutt, A. J., Ilstrup, D. M., & Carney, J. A. (1985). Carcinoid tumors of the gastrointestinal tract: Presentation, management, and prognosis. Surgery, 98, 1054-1063.
31. Tschop, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., & Heiman, M. L. (2001). Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709.
32. Tsolakis, A. V., Portela-Gomes, G. M., Stridsberg, M., Grimelius, L., Sundin, A., Eriksson, B. K., et al. (2004). Malignant gastric ghrelinoma with hyperghrelinemia. Journal of Clinical Endocrinology and Metabolism, 89, 3739-3744.
33. Volante, M., Allia, E., Gugliotta, P., Funaro, A., Broglio, F., Deghenghi, R., et al. (2002). Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. Journal of Clinical Endocrinology and Metabolism, 87, 1300-1308.
34. Wierup, N., Svensson, H., Mulder, H., & Sundler, F. (2002). The ghrelin cell: A novel developmentally regulated islet cell in the human pancreas. Regulatory Peptides, 107, 63-69.